Brief: Hofseth Biocare Says Atlantic Sapphire And Co Sign LOI To Establish Joint Venture In Miami, U.S.
Nov 1 (Reuters) - Hofseth Biocare Asa HOFBC.OL :
* ATLANTIC SAPPHIRE AS AND HOFSETH BIOCARE ASA SIGN LOI TO
ESTABLISH A JOINT VENTURE IN MIAMI, US
* HBC - ATLANTIC SAPPHIRE, CO AIM TO ENTER INTO DEFINITIVE
AGREEMENT IN Q1 2020, BEGIN LIMITED PRODUCTION IN Q4, 2020
* ATLANTIC SAPPHIRE AND HBC AIMS TO INCREASE OUTPUT ONCE
ATLANTIC
SAPPHIRE BEGINS 20,000T (HOG) ANNUAL PRODUCTION
Source text for Eikon: ID:nGNE2V4GgX
Further company coverage: HOFBC.OL
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atlantic Sapphire ASA
See all newsBrief: Oslo Bors Decides To Delist Shares Of Atlantic Sapphire
Brief: Coral HoldCo Acquires Remaining Atlantic Sapphire Shares
Brief: Atlantic Sapphire To Raise Additional Bridge Loan Tranche
Brief: Atlantic Sapphire Says CFO And Deputy CEO To Step Down At The End Of 2026
Brief: Atlantic Sapphire ASA Secures USD 20M Liquidity